Echo Therapeutics (ECTE) Reports Q3 Loss of $0.04
Tweet
Share
E-mailGet Alerts ECTE Hot Sheet
Price: $0.00 --0%
Financial Fact:
Selling, general and administrative: 1.2M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Financial Fact:
Selling, general and administrative: 1.2M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Echo Therapeutics (NASDAQ: ECTE) reported Q3 EPS of ($0.04), versus ($0.02) reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Universal Logistics Holdings, Inc. (ULH) Tops Q1 EPS by 136c
- Byline Bancorp (BY) Tops Q1 EPS by 6c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
